157. スタージ・ウェーバー症候群 [臨床試験数:8,薬物数:11(DrugBank:4),標的遺伝子数:5,標的パスウェイ数:62

Searched query = "Sturge-Weber syndrome", "Síndrome de Sturge-Weber"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04447846October 14, 201910/10/2019Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber SyndromeNovel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: A Phase II TrialSturge-Weber SyndromeDrug: CannabidiolAnne Comi, MDGW Pharmaceuticals Ltd.;Faneca 66 FoundationRecruiting3 Years50 YearsAll10Phase 2United States
2NCT02332655December 20145/1/2015Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeCannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeSturge-Weber SyndromeDrug: CannabidiolAnne Comi, MDGW Pharmaceuticals Ltd.;Faneca 66 FoundationActive, not recruiting1 Month45 YearsAll5Phase 1/Phase 2United States